Chimerix Investor Conference Presentation Deck slide image

Chimerix Investor Conference Presentation Deck

ā— ā— Case Study Integrated Diagnosis: DMG, H3K27m mutation Molecular Features: MGMT promoter unmethylated, IDH wildtype. Significant response to treatment both by RANO- HGG and RANO-LGG by cycles 8 and 10; response was sustained for over one year 18 T1 POST Contrast FL Baseline LTH Cycle 8 Cycle 10
View entire presentation